Company: KMRK
Filing Date: 2025-01-02
Form Type: DRS
Source: 0001213900-25-000267
Chunk: 17

Company: K-TECH SOLUTIONS CO LTD
Filing Date: 2025-01-02
Form: DRS
Chunk 17
---
 reorganization in contemplation of this offering, we completed a share swap transaction, pursuant to which KTech acquired all the issued shares of KMT from Mr.Kwok Yiu Fai, Mr.Kwok Yiu Keung and Mr.Kwok Yiu Wah by way of allotting and issuing an aggregate of [19,470,000] ordinary shares to them. On December30, 2024, our Controlling Shareholders sold a total of [3,000,000] ordinary shares to five corporations, all of whom have no affiliation with us. On [*], the Company passed a written resolution to re -designateand re -classifyits existing authorized ordinary shares. Prior to the re -classificationexercise, the Company is authorized to issue a maximum of 500,000,000 ordinary shares of a single class with a par value of USD0.0001 each. Subsequent to the re -classificationexercise, the Company’s authorized shares was 500,000,000 ordinary shares with a par value of US$0.0001 each comprising (a) [*] Class A Shares with a par value of US$0.0001 each; and (b) [*] Class B Shares with a par value US$0.0001 each. On [*], the Company had [18,000,000] Class A Shares and [1,500,000] Class B Ordinary Shares, issued and outstanding, respectively. Holders of Class A Shares and Class B Shares vote together as one class on all matters submitted to a vote by the shareholders at any general meeting of the Company and have the same rights except each Class A Share is entitled to one (1) vote and each Class B Share is entitled to ten (10) votes. All such Class B Ordinary Shares are held by our Controlling Shareholders. For a description of the reorganization primarily to facilitate our IPO in the U.S, see “ Corporate History and Structure — Reorganization.” Immediately following this offering and the sale of our Shares by the Selling Shareholders pursuant to the Resale Prospectus, our Controlling Shareholders will hold [69.9]% of our outstanding Shares or [81.4]% of the total voting power of the Company, assuming [*] Shares are issued in the offering and no exercise of the overallotment option (or [*]% of our outstanding Shares or [*]% of the total voting power if the underwriters exercise their over -allotmentoption). As a result of the Acting in Concert Agreement, our